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PREFACE 
Proceedings of 31st Annual Symposium on the Biology of Skin 
Structural Elements of the Dermis 
The importance of the extracellular connective tissue matrix 
should be obvious to everyone; without it, man would be 
reduced to a dump of cells interconnected by a few neurons. 
The theme of the 31st Annual Symposium on the Biology of 
Skin, held in Gleneden Beach, OR, in October 1981, was the 
Structural Elements of the Dermis. As organizers of the Sym­
posium, we believe that this topic was extremely timely, for 
several reasons. First, the biochemical research on the structure 
and metabolism of connective tissue components, collagen, 
elastin, and the proteoglycans, has reached a new level of 
sophistication, as pointed out by the keynote speaker Dr. Dar­
win J. Prockop. For example, considerable progress has been 
made in the understanding of the gene structures of collagen 
and elastin, and further application of the recombinant DNA 
technology holds a promise of breakthroughs in the future. 
Secondly, the progress made in the basic biology of connective 
tissues has provided us with means to explore possible defects 
in a variety of diseases. It is now well appreciated that a 
molecular aberration in collagen is the underlying defect in 
patients with heritable disorders of connective tissue, such as 
the Ehlers-Danlos syndrome and osteogenesis imperfecta. On 
the other hand, modulation of collagen metabolism by immu­
nologic means or through cell selection clearly is of importance 
in acquired clinical conditions, as for example in progressive 
systemic sclerosis. Furthermore, considerable amount of re­
search is in progress to elucidate the nature of elastin abnor­
malities in conditions like pseudoxanthoma elasticum, cutis 
laxa and the Marfan syndrome. The third point contributing to 
the timeliness of this topic is derived from the fact that with 
increasing knowledge of the etiologic and pathogenic mecha­
nisms, workers are now ready to initiate studies to formulate 
rational treatment modalities to counteract these diseases. 
Thus, for example, appreciation of the fact that excessive ac­
cumulation of collagen in scleroderma is a result of increased 
synthesis rather than reduced degradation of the protein, has 
Is 
directed our attention to pharmacologic means which might be 
promising in inhibiting collagen production by fibroblasts. On 
the other hand, demonstration of increased levels of collagenase 
in patients with recessive dystrophic epidermolysis bullosa has 
prompted a search of pharmacologic inhibitors of this pro­
teinase. 
The meeting was a great success in bringing together scien­
tists representing the whole spectrum of the modern biomedical 
research: They came from laboratories specializing in cloning 
of genes, they represented pharmaceutical industry with inter­
est in drug development, or they were clinical dermatologists 
eager to update their knowledge in diseases with which they 
deal in everyday practice. We believe that the scientific en­
counter between such a diverse group of professionals is the 
best means in advancing our knowledge of disease. The natural 
beauty of the Oregon coast and the friendly atmosphere of the 
Salishan Lodge provided us again with a setting which makes 
this sort of gathering a most enjoyable experience to all of '.IS. 
This Symposium Issue summarizes the highlights of our 
progress in connective tissue research at the end of 1981. In 
addition to specific scientific achievements, many of these con­
tributions enter to more speculative areas of research. These 
speculations should stimulate our thinking and provide us with 
information on which further research on the extracellular 
matrix of the dermis can be based for years to come. 
The 31st Annual Symposium on the Biology of Skin was 
sponsored by the Cutaneous Biology Foundation, Inc. and The 
Oregon Health Sciences University. Support for the meeting 
came from a grant from the Public Health Service AM 09431, 
the Medical Research Foundation of Oregon and contributions, 
largely from the pharmaceutical and cosmetic industries. 
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